BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases.

Biotechnology

BioMarin Pharmaceutical

Alexander Hardy

Hank Fuchs

Marcia Kayath

Patrice Lebrun

Cristin Hubbard

Shannon Utter

Humaira Serajuddin

Eduardo von Pervieux

Kevin Eggan

Marni Kottle

C. Greg Guyer

Brian R. Mueller

G. Eric Davis

Brinda Balakrishnan

Amy Wireman

Leadership Team

Commercial Operations and Strategy

Research and Development

Quality Assurance and Compliance

Clinical and Regulatory Affairs

Teams at BioMarin Pharmaceutical

Leadership Team

Commercial Operations and Strategy

Research and Development

Quality Assurance and Compliance

Clinical and Regulatory Affairs